Paul W. Armstrong

82.2k total citations · 11 hit papers
850 papers, 38.3k citations indexed

About

Paul W. Armstrong is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul W. Armstrong has authored 850 papers receiving a total of 38.3k indexed citations (citations by other indexed papers that have themselves been cited), including 679 papers in Cardiology and Cardiovascular Medicine, 243 papers in Surgery and 178 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul W. Armstrong's work include Acute Myocardial Infarction Research (393 papers), Cardiac Imaging and Diagnostics (169 papers) and Heart Failure Treatment and Management (151 papers). Paul W. Armstrong is often cited by papers focused on Acute Myocardial Infarction Research (393 papers), Cardiac Imaging and Diagnostics (169 papers) and Heart Failure Treatment and Management (151 papers). Paul W. Armstrong collaborates with scholars based in Canada, United States and United Kingdom. Paul W. Armstrong's co-authors include Justin A. Ezekowitz, Finlay A. McAlister, Christopher B. Granger, Eric J. Topol, Frans Van de Werf, Harvey D. White, Robert M. Califf, Robert M. Califf, Maarten L. Simoons and Robert A. Harrington and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Paul W. Armstrong

832 papers receiving 36.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

2015 1.9k citations Jennifer B. Green, Paul W. Armstrong et al. profile →
The Effects of Climate Change on Cardiac Health

2015 1.2k citations Justin A. Ezekowitz, Paul W. Armstrong et al. profile →
Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1996 859 citations E. Magnus Ohman, Paul W. Armstrong et al. profile →
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

1999 833 citations Paul W. Armstrong, Barry M. Massie et al. Circulation profile →
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation

2000 716 citations Karen S. Pieper, Paul W. Armstrong et al. Circulation profile →
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

2003 678 citations Justin A. Ezekowitz, Finlay A. McAlister et al. Circulation profile →
Acute Coronary Care in the Elderly, Part I

2007 677 citations L. Kristin Newby, Paul W. Armstrong et al. Circulation profile →
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

2002 650 citations Harvey D. White, Frans Van de Werf et al. profile →
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

2008 619 citations Paul W. Armstrong et al. Journal of the American College of Cardiology profile →
Renal Insufficiency and Heart Failure

2004 532 citations Finlay A. McAlister, Justin A. Ezekowitz et al. Circulation profile →
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

2020 184 citations Paul W. Armstrong, Carolyn S.P. Lam et al. profile →

Peers

Countries citing papers authored by Paul W. Armstrong

Since Specialization

Citations

This map shows the geographic impact of Paul W. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Armstrong more than expected).

Fields of papers citing papers by Paul W. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Armstrong. The network helps show where Paul W. Armstrong may publish in the future.

Co-authorship network of co-authors of Paul W. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Paul W. Armstrong. A scholar is included among the top collaborators of Paul W. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul W. Armstrong. Paul W. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship Between Baseline Electrocardiographic Measurements and Outcomes in Patients with High-Risk Heart Failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) Trial 2023 ·European Journal of Heart Failure ·Haran Yogasundaram, Yinggan Zheng, (unknown), Justin A. Ezekowitz, Piotr Ponikowski, Carolyn S.P. Lam, Christopher M. O’Connor, Robert O. Blaustein, Lothar Roessig, (unknown), Cynthia M. Westerhout, Paul W. Armstrong, Roopinder K. Sandhu, (unknown)	3
2	Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes 2023 ·JCI Insight ·Jessica A. Regan, Robert J. Mentz, (unknown), Jennifer B. Green, L. Truby, Olga Ilkayeva, Christopher B. Newgard, John B. Buse, Harald Sourij, C. David Sjöström, Naveed Sattar, Robert W. McGarrah, Yinggan Zheng, Darren K. McGuire, Eberhard Standl, Paul W. Armstrong, Eric D. Peterson, Adrian F. Hernandez, Rury R. Holman, Svati H. Shah	9
3	STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial 2023 ·Circulation ·Frans Van de Werf, Arsen Ristić, О. В. Аверков, Alexandra Arias‐Mendoza, Yves Lambert, José Francisco Kerr Saraiva, Pablo Sepúlveda, Fernando Rosell Ortiz, J. French, (unknown), Katleen Vandenberghe, Kris Bogaerts, Cynthia M. Westerhout, (unknown), Thierry Danays, Kevin R. Bainey, Peter Sinnaeve, Patrick Goldstein, Robert C. Welsh, Paul W. Armstrong, (unknown)	19
4	Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial 2021 ·Journal of Cardiac Failure ·Robert J. Mentz, Hillary Mulder, Arend Mosterd, Nancy K. Sweitzer, Michele Senni, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Burkert Pieske, Piotr Ponikowski, Adriaan A. Voors, Kevin J. Anstrom, Paul W. Armstrong, Christopher M. O’Connor, Adrian F. Hernandez	12
5	Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine 2021 ·Diabetes Care ·Abhinav Sharma, Yinggan Zheng, Justin A. Ezekowitz, Cynthia M. Westerhout, Jacob A. Udell, Shaun G. Goodman, Paul W. Armstrong, John B. Buse, Jennifer B. Green, Robert G. Josse, Keith D. Kaufman, Darren K. McGuire, Giuseppe Ambrosio, Lee‐Ming Chuang, Renato D. Lópes, Eric D. Peterson, Rury R. Holman	30
6	Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype 2018 ·Diabetes Care ·Eberhard Standl, Susanna R. Stevens, Paul W. Armstrong, John B. Buse, Juliana C.N. Chan, Jennifer B. Green, John M. Lachin, André Scheen, F. Travert, Frans Van de Werf, Eric D. Peterson, Rury R. Holman	49
7	Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS 2018 ·Diabetes Obesity and Metabolism ·Joakim Alfredsson, Jennifer B. Green, Susanna R. Stevens, Shelby D. Reed, Paul W. Armstrong, M. Angelyn Bethel, Samuel S. Engel, Darren K. McGuire, Frans Van de Werf, Irene Hramiak, Harvey D. White, Eric D. Peterson, Rury R. Holman, (unknown)	25
8	Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial 2017 ·Diabetes Care ·Abhinav Sharma, Jennifer B. Green, Allison Dunning, Yuliya Lokhnygina, Sana M. Al‐Khatib, Renato D. Lópes, John B. Buse, John M. Lachin, Frans Van de Werf, Paul W. Armstrong, Keith D. Kaufman, Eberhard Standl, Juliana C.N. Chan, Larry A. Distiller, Russell Scott, Eric D. Peterson, Rury R. Holman	53
9	Loop Diuretic Dose Adjustments after a Hospitalization for Heart Failure: Insights From ASCEND-HF 2015 ·European Journal of Heart Failure ·Adam D. DeVore, Vic Hasselblad, Robert J. Mentz, Christopher M. O’Connor, Paul W. Armstrong, John J.V. McMurray, Justin A. Ezekowitz, W.H. Wilson Tang, Randall C. Starling, Adriaan A. Voors, Robert M. Califf, Adrian F. Hernandez	19
10	The Relationship between Left Ventricular Ejection Fraction and Mortality in Patients with Acute Heart Failure: Insights from the ASCEND-HF Trial 2013 ·European Journal of Heart Failure ·Mustafa Toma, Justin A. Ezekowitz, Jeffrey A. Bakal, Christopher M. O’Connor, Adrian F. Hernandez, Muhammad Sardar, Ronald Zolty, Barry M. Massie, Karl Swedberg, Paul W. Armstrong, Randall C. Starling	52
11	Troponin I in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Study 2012 ·European Journal of Heart Failure ·G. Michael Felker, Vic Hasselblad, W.H. Wilson Tang, Adrian F. Hernandez, Paul W. Armstrong, Gregg C. Fonarow, Adriaan A. Voors, Marco Metra, John J.V. McMurray, Javed Butler, Gretchen Heizer, Kenneth Dickstein, Barry M. Massie, Dan Atar, Richard W. Troughton, Stefan D. Anker, Robert M. Califf, Randall C. Starling, Christopher M. O’Connor	87
12	Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial 2012 ·American Heart Journal ·Rajendra H. Mehta, Padma Kaul, Renato D. Lópes, Manesh R. Patel, Yinggan Zheng, Karen S. Pieper, Robert C. Welsh, Paul W. Armstrong, Christopher B. Granger	6
13	Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone concentrations in ST elevation myocardial infarction: An analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial 2010 ·Critical Care Medicine ·Rudolf Járai, Kurt Huber, Kris Bogaerts, Peter Sinnaeve, Justin A. Ezekowitz, Allan M. Ross, Uwe Zeymer, Paul W. Armstrong, Frans Van de Werf	14
14	Patient and Informal Caregivers’ Knowledge of Heart Failure: Necessary but Insufficient for Effective Self-Care 2009 ·European Journal of Heart Failure ·Alexander M. Clark, (unknown), Finlay A. McAlister, Ross T. Tsuyuki, Paul W. Armstrong, Laurel A. Strain	102
15	Tenecteplase-pretrearted STEMI patients with TIMI 0-2 flow before PCI are less likely to have TIMI 3 flow after PCI 2007 ·Journal of the American College of Cardiology ·Walter Desmet, Allan M. Ross, Christopher B. Granger, Paul W. Armstrong, (unknown)	0
16	Interinstitutional variation in the use of abciximab for percutaneous coronary intervention. 2004 ·PubMed ·Cynthia M. Westerhout, L. Duncan Saunders, Padma Kaul, Paul W. Armstrong, Merril L. Knudtson, William A. Ghali	1
17	Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience 2002 ·Annals of Emergency Medicine ·W. Brian Gibler, Paul W. Armstrong, E. Magnus Ohman, W. Douglas Weaver, Amanda Stebbins, Joel M. Gore, L. Kristin Newby, Robert M. Califf, Eric J. Topol	102
18	Unrepresentative, invalid and misleading: are waiting times for elective admission wrongly calculated? 2000 ·PubMed ·Paul W. Armstrong	5
19	Innovative legislative initiatives: the New Jersey Declaration of Death and Advance Directives for Health Care Acts. 1992 ·PubMed ·Paul W. Armstrong, Robert S. Olick	1
20	Prinzmetal's angina, normal coronary arteries and pericarditis. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Joshua R. Lewis, Robert Kisilevsky, Paul W. Armstrong	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact